Earnings Call Summary | IRIDEX(IRIX.US) Q1 2024 Earnings Conference
The following is a summary of the IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript:Financial Performance:In Q1 2024, IRIDEX recorded total revenue of $11.8 million, a significant decrease fr
IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript
IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript
Iridex on the Brink: Operational Losses and Funding Woes Threaten Company Viability
Iridex Price Target Maintained With a $2.00/Share by Stifel
Iridex Price Target Maintained With a $2.00/Share by Stifel
Stifel: Maintaining the Iridex (IRIX.US) rating, adjusted from holding to holding, with a target price of $2.00.
Stifel: Maintaining the Iridex (IRIX.US) rating, adjusted from holding to holding, with a target price of $2.00.
Stifel Maintains Hold on Iridex, Maintains $2 Price Target
Stifel analyst Thomas Stephan maintains Iridex (NASDAQ:IRIX) with a Hold and maintains $2 price target.
Iridex Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 -31.27% Stifel → $2 Maintains Hold 08/26/2022 3.09% Stifel $5 → $3 Downgrades Buy → Hold 05/12/
Q1 2024 IRIDEX Corp Earnings Call
Analysts Offer Insights on Healthcare Companies: Iridex (IRIX), Nyxoah (NYXH) and Enliven Therapeutics (ELVN)
IRIDEX Corp (IRIX) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges With ...
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
IRIDEX | 10-Q: Quarterly report
IRIDEX Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.
IRIDEX Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.
Earnings Flash (IRIX) IRIDEX CORPORATION Posts Q1 Revenue $11.8M, Vs. Street Est of $12M
04:08 PM EDT, 05/14/2024 (MT Newswires) -- Earnings Flash (IRIX) IRIDEX CORPORATION Posts Q1 Revenue $11.8M, vs. Street Est of $12M
Iridex 1Q Loss/Shr 21c >IRIX
Iridex 1Q Loss/Shr 21c >IRIX
Press Release: Iridex Reports First Quarter 2024 Financial Results
Iridex Reports First Quarter 2024 Financial Results MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile la
Even After Rising 11% This Past Week, IRIDEX (NASDAQ:IRIX) Shareholders Are Still Down 59% Over the Past Three Years
Earnings Preview: IRIDEX to Report Financial Results Post-market on May 14
$IRIDEX(IRIX.US)$ is scheduled to release its financial results post-market on May 14. Earnings PreviewAnalysts estimate $IRIDEX(IRIX.US)$ to post revenue of USD12 million for 2024Q1, down 12.45% YoY;
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) shares increased by 73.2% to $1.1 during Thursday's after-market session. The company's market cap stands at $39.3 million. Sunshine Biopharma (NASDAQ:SBFM) sha
Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX), Iridex (IRIX) and Keros Therapeutics (KROS)
No Data